Combination of Atezolizumab, Bevacizumab, and Chemotherapy (IMpower 150) in a Patient With NSCLC Having Leptomeningeal Metastases

Jordi Remon; María Castro-Henriques; Laura Esteller; Josep Vives

doi:10.1016/j.jtocrr.2020.100096

Combination of Atezolizumab, Bevacizumab, and Chemotherapy (IMpower 150) in a Patient With NSCLC Having Leptomeningeal Metastases

Jordi Remon, María Castro-Henriques, Laura Esteller, Josep Vives

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)

Original language	English
Article number	100096
Journal	JTO Clinical and Research Reports
Volume	2
Issue number	1
DOIs	https://doi.org/10.1016/j.jtocrr.2020.100096
Publication status	Published - 1 Jan 2021
Externally published	Yes

Access to Document

10.1016/j.jtocrr.2020.100096

Cite this

@article{ef7e227b8b914492983b8bb4182ba3c8,

title = "Combination of Atezolizumab, Bevacizumab, and Chemotherapy (IMpower 150) in a Patient With NSCLC Having Leptomeningeal Metastases",

author = "Jordi Remon and Mar{\'i}a Castro-Henriques and Laura Esteller and Josep Vives",

note = "Funding Information: The authors thank the patient involved in this study who gave his informed consent, authorizing the use and disclosure of his health information. Dr. Remon wrote the original draft of the manuscript, whereas Castro-Henriques, Esteller, and Vives contributed to the review and editing of the manuscript.",

year = "2021",

month = jan,

day = "1",

doi = "10.1016/j.jtocrr.2020.100096",

language = "English",

volume = "2",

journal = "JTO Clinical and Research Reports",

issn = "2666-3643",

number = "1",

}

TY - JOUR

T1 - Combination of Atezolizumab, Bevacizumab, and Chemotherapy (IMpower 150) in a Patient With NSCLC Having Leptomeningeal Metastases

AU - Remon, Jordi

AU - Castro-Henriques, María

AU - Esteller, Laura

AU - Vives, Josep

N1 - Funding Information: The authors thank the patient involved in this study who gave his informed consent, authorizing the use and disclosure of his health information. Dr. Remon wrote the original draft of the manuscript, whereas Castro-Henriques, Esteller, and Vives contributed to the review and editing of the manuscript.

PY - 2021/1/1

Y1 - 2021/1/1

UR - http://www.scopus.com/inward/record.url?scp=85109518912&partnerID=8YFLogxK

U2 - 10.1016/j.jtocrr.2020.100096

DO - 10.1016/j.jtocrr.2020.100096

M3 - Article

AN - SCOPUS:85109518912

SN - 2666-3643

VL - 2

JO - JTO Clinical and Research Reports

JF - JTO Clinical and Research Reports

IS - 1

M1 - 100096

ER -

Combination of Atezolizumab, Bevacizumab, and Chemotherapy (IMpower 150) in a Patient With NSCLC Having Leptomeningeal Metastases

Access to Document

Other files and links

Cite this